KEYNOTE SPEAKERS

Edoardo CharbonMonday 26th

Biography

    Edoardo CHARBON received the diploma from ETH Zürich, Switzerland, the M.S. from U.C. San Diego, and the Ph.D. from U.C. Berkeley in 1988, 1991, and 1995, respectively, all in electrical engineering and EECS. He was with Cadence Design Systems from 1995 to 2000, where he was the architect of the company’s initiative on information hiding for intellectual property protection. In 2000, he joined Canesta Inc., as Chief Architect, where he led the development of time-of-flight 3-D CMOS image sensors. From 2002 to 2008 he was assistant professor at EPFL; in 2008 he joined TU Delft as Chair of VLSI Design and in 2015 EPFL as Chair of Advanced Quantum Architectures. He has authored and co-authored over 250 papers in journals, conference proceedings, magazines, and two books, and he holds 20 patents. His current research interests include 3-D imaging, single-photon imaging, space-based detection, quantum-inspired circuits and systems, and cryo-CMOS technologies. Prof. Charbon has been a Guest Editor of numerous IEEE journals and a member of the TPCs of ISSCC, ESSCIRC, ICECS, ISLPED, VLSI-SOC, and IEDM. He is a Distinguished Visiting Scholar with the W. M. Keck Institute for Space, California Institute of Technology, Pasadena, CA, a fellow of the Kavli Institute of Nanoscience Delft, and a fellow of the IEEE.

Keynote presentation:Photon counting in imagers: good to have or necessity?

    The appearance of solid-state, miniaturized single-photon detectors has enabled massively parallel conversion of photons to digital signals that can be readily processed and/or transported with negligible losses. As a consequence, a new class of imaging sensors is emerging, known collectively as all-digital image sensors, for detection and processing of ultra-fast and complex photonic events, often present in biomedical imaging systems. All-digital image sensors, also known as photon-counting imagers, are fast and robust, often enabling unprecedented accuracy in a number of biomedical imaging modalities, including PET, SPECT, NIROT, FLIM, FRET, etc. This talk describes several all-digital image sensors, including SiPMs for all-digital biomedical imaging designed to efficiently process large data volumes, so as to minimize power dissipation, improve flexibility, and shorten overall time-to-market.

Nando BasileTuesday 27th

Biography

    Nando BASILE is a reference for the ULP Technology Marketing in X-FAB, encompassing best-in class ultra-low-power technology specifically oriented to the sensor market. He has more than 20 years of experience in semiconductor Process, Technology R&D and Design with major semiconductor companies (Texas Instruments, Micron Technology, STMicroelectronics). Since 2010, he promotes collaborations with international competence centers and industrial partners for specific ULP technologies intended to smart grids and autonomous sensor markets.

    As a side activity, he supports start-up specifically aimed to fast autonomous sensor prototyping and energy harvesting and he is in the technical board in the organization of international sensor conferences and events.

Keynote presentation:Ultra-Low Power CMOS Platforms for Smart Sensors

    The Internet of Things (IoT) translates the connectivity and information treatment of countless sensors to a world scale and at different levels of networking. In the overwhelming majority of applications, the electronics needed for sensors’ operation has to run on battery or energy harvesting, resulting is in constrained conditions in terms of available energy and power. The choice of the correct CMOS platform granting for reliable and long-term sensor functionality, by carefully optimising active power consumption and stand-by power when in sleep mode, becomes therefore critical.

    This presentation aims to provide a bird-view about the key functionalities for sensor networks and how they call for specific design solutions, demanding in turn for specific CMOS platform key features and indicators. The hoped goal would be helping smart sensor solutions providers in better choosing key semiconductor partners and technologies to secure the success for their application.

Pantelis GeorgiouWednesday 28th

Biography

    Pantelis GEORGIOU currently holds the position of Senior Lecturer at Imperial College London within the Department of Electrical and Electronic Engineering. He is the head of the Bio-inspired Metabolic Technology Laboratory in the Centre for Bio-Inspired Technology; a multi-disciplinary group that invents, develops and demonstrates advanced micro-devices to meet global challenges in biomedical science and healthcare. His research includes ultra-low power micro-electronics, bio-inspired circuits and systems, lab-on-chip technology and application of micro-electronic technology to create novel medical devices. One of his key research areas is new technologies for treatment of diabetes such as the artificial pancreas but also develops novel Lab-on-Chip technology with application in genomics and diagnostics targeted towards infectious disease and antimicrobial resistance (AMR), in addition to wearable technologies for rehabilitation of chronic conditions.

    Dr. Georgiou graduated with a 1st Class Honours MEng Degree in Electrical and Electronic Engineering in 2004 and Ph.D. degree in 2008 both from Imperial College London. He then joined the Institute of Biomedical Engineering as Research Associate until 2010, when he was appointed Head of the Bio-inspired Metabolic Technology Laboratory. In 2011, he joined the Department of Electrical & Electronic Engineering, where he currently holds an academic faculty position. He conducted pioneering work on the silicon beta cell and is now leading the project forward to the development of the first bio-inspired artificial pancreas for treatment of Type I diabetes. In addition to this, he made significant contributions to the development of integrated chemical-sensing systems in CMOS. He has pioneered the development of the Ion-Sensitive Field Effect Transistor, an integrated pH sensor which is currently being used in next generation DNA sequencing machines, demonstrating for the first time its use in low-power weak-inversion, and its capability in a multimodal sensing array for Lab-on-Chip applications. Dr. Georgiou is a senior member of the IEEE and IET and serves on the BioCAS and Sensory Systems technical committees of the IEEE CAS Society. He is an associate editor of the IEEE Sensors and TBioCAS journals. He is also the CAS representative on the IEEE sensors council. In 2013 he was awarded the IET Mike Sergeant Achievement Medal for his outstanding contributions to engineering and development of the bio-inspired artificial pancreas. He is currently an IEEE Distinguished Lecturer in Circuits and Systems.

Keynote presentation:Bio-Inspired microelectronics for improving human health

    In the last decade, we have seen a convergence of microelectronics into the world of healthcare providing novel solutions for early detection, diagnosis and therapy of disease. This has been made possible due to the emergence of CMOS technology, allowing fabrication of advanced systems with complete integration of sensors, instrumentation and processing, enabling design of miniaturised medical devices which operate with low-power.

    In this talk I present how my lab is applying microelectronics to improve human health. Specifically, I will focus on two areas: the first will be on the management of chronic disease using Bio-Inspired technology, whereby low-power CMOS-based systems can be designed to replicate biology to provide portable personalized medical devices such as the Bio-Inspired Artificial Pancreas (BiAP), which we have developed for closed-loop control of blood glucose used in the management of Diabetes. The second is on rapid screening of disease, whereby advances in CMOS-based Ion-Sensitive Field Effect Transistor technology (ISFETs) is now allowing implementation large chemical sensor arrays for point-of-care diagnostic systems as well as DNA sequencing platforms which are used in early diagnosis and screening in hospitals.